Skip to content

Clinical trials

Phase 2 Musculoskeletal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Phase: Phase 2 Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20081
20091
20112
20121
20134
20143
20153
20161
20171
20181
20195
20206
20214
20224
20232
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated10
Recruiting4
Active, not recruiting4
Enrolling by invitation3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
BioMarin Pharmaceutical4
QED Therapeutics, a BridgeBio company4
Fulcrum Therapeutics3
Northwestern University3
Amgen2
Erasme University Hospital2
Kezar Life Sciences, Inc.2
Atlantic Health System1
Avidity Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases49
Arthritis16
Bone Diseases16
Joint Diseases14
Rheumatic Diseases9
Dwarfism8
Genetic Diseases, Inborn8
Achondroplasia7
Osteoarthritis7
Arthritis, Rheumatoid6

Trials

Showing 51 to 49 of 49. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.